Cytokinins Reduce Viral Replication and Alter Plaque Morphology of Frog Virus 3 In Vitro
Open Access
Abstract
Cytokinins (CKs) are a group of N6-substituted signaling molecules whose biosynthesis and metabolism have been documented in all kingdoms of life, including vertebrates. While their biological relevance in vertebrate systems continues to be elucidated, they have broadly been documented with therapeutic effects in exogenous applications. In this study, we evaluated the virostatic potential of four types of CKs including, N6-isopentenyladenine (iP), N6-isopentenyladenosine (iPR), N6-isopentenyladenosine-5′monophosphate (iPMP), and 2-methylthiol-N6-isopentenyladenosine (2MeSiPR) against the ranavirus type species, frog virus 3 (FV3). Following concurrent treatment and infection, iP and iPR reduced viral replication by 33.8% and 59.6%, respectively, in plaque formation assays. A decrease in viral replication was also observed when CK exposure was limited to 12 h prior to infection, where iP and iPR reduced viral replication by 31% and 23.75%, respectively. Treatment with iP and iPR was also marked by 48% and 60% decreases in viral load over 72 h, respectively, as measured in single step growth curves. Plaque morphology was altered in vitro, as iP and iPR treatment increased plaque area by 83% and 112% with lytic zone formation also becoming more prevalent in corresponding treatments. Treatment with iPMP and 2MeSiPR resulted in no effect on viral kinetics in vitro. The results of this study are the first to provide evidence of CK antiviral activity against a DNA virus and highlight the importance of their structure for therapeutic investigations.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-04843, RGPIN-05436, 534378-2019)
This publication has 51 references indexed in Scilit:
- Substrate binding modes of purine and pyrimidine nucleotides to human ecto-5′-nucleotidase (CD73) and inhibition by their bisphosphonic acid derivativesPurinergic Signalling, 2021
- N6‐Isopentenyladenosine in RNA Determines the Cleavage Site of Endonuclease DeoxyribozymesAngewandte Chemie International Edition, 2020
- Virus–Host Coevolution with a Focus on Animal and Human DNA VirusesJournal of Molecular Evolution, 2019
- Anti-cancer activities of cytokinin ribosidesPhytochemistry Reviews, 2019
- The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cellsInflammation Research, 2017
- Putative role of the adenosine A3 receptor in the antiproliferative action of N 6-(2-isopentenyl)adenosinePurinergic Signalling, 2011
- Involvement of Akt/NF‐κB pathway in N6‐isopentenyladenosine‐induced apoptosis in human breast cancer cellsMolecular Carcinogenesis, 2010
- The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A (p21) upregulation in human cancer cell linesBiochemical Pharmacology, 2009
- N6‐isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1International Journal of Cancer, 2008
- Frog virus 3-mediated translational shut-off: frog virus 3 messages are translationally more efficient than host and heterologous viral messages under conditions of increased translational stressVirus Research, 1990